Bone Marrow Transplantation News

New guidelines for vaccinating adults with solid or hematologic cancers detailed the importance of vaccination optimization, multidisciplinary coordination and vaccination of household members.

Myelodysplastic syndrome predominantly affects older adults, with median age of onset of 70 years.

A sequential chimeric antigen receptor T-cell therapy and haploidentical hematopoietic stem cell transplantation strategy conferred remissions in certain patients with relapsed or refractory CD7-positive hematologic cancers.

Matt Kalaycio, MD, FACP, has been elected chair of National Comprehensive Cancer Network’s board of directors.

Chronic graft-versus-host disease was associated with clinically meaningful quality of life impairment and symptom burden, making patient-reported outcomes an important prognostic marker, according to a study.

Among elderly patients with acute myeloid leukemia, survival outcomes for those who received an allogenic stem cell transplant have improved significantly over the past 2 decades, according to data published in Clinical Cancer Research.

Most of the major cancer clinical trial centers in the U.S. are located near more affluent and white populations compared with the national average, according to results published in JAMA Oncology.

A multimodal phone app proved feasible for addressing sexual dysfunction among hematopoietic stem cell transplant survivors, according to results presented at Tandem Meeting | Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR.

The first published results of a phase 3 allogeneic T-cell therapy showed a better than 50% response rate in patients with relapsed or refractory Epstein-Barr virus-positive post-transplant lymphoproliferative disease.

Topical ruxolitinib cream significantly reduced skin manifestations caused by cutaneous graft-versus-host disease compared with vehicle cream, results from a randomized phase 2 study showed.